Local shares burst higher today following a positive night on Wall Street. However, one big-name business didn’t get to enjoy the rally as its shares plummeted.

First, here’s a quick recap:

  • S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) up 0.6% to 5442 points
  • ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) up 0.6% to 5523 points
  • AUD/USD at US 76.25 cents
  • Iron Ore at US$59.28 a tonne, according to the Metal Bulletin
  • Gold at US$1,266.21 an ounce
  • Brent oil at US$51.31 a barrel

Bega Cheese Ltd (ASX: BGA) was the unlucky business that fell 16.8% today, making it the worst from the ASX 200 cohort.

The company forecast flat earnings for the year ahead, while its recent joint venture with Blackmores Limited (ASX: BKL) doesn’t appear to be going to plan. Blackmores’ shares fell a more respectable 1.1%.

JB Hi-Fi Limited (ASX: JBH) and EVOLUTION FPO (ASX: EVN) also struggled today, shedding 2.3% and 2.7%, respectively.

Meanwhile, shares of Ardent Leisure Group (ASX: AAD) plunged 7.8% late in the afternoon. It has been reported that at least one person has tragically died following a theme park accident at Dreamworld, owned by Ardent Leisure.

On a far more positive note, shares of Fortescue Metals Group Limited (ASX: FMG) rocketed 6.5%, with Rio Tinto Limited (ASX: RIO) rising 2.4%.

Westpac Banking Corp (ASX: WBC) was the top-performing bank, rising 1.1%, while Coca-Cola Amatil Ltd (ASX: CCL) regained 2.2% after yesterday’s selloff.

Speaking of sell-offs, Healthscope Ltd (ASX: HSO) also recovered 1.8% today, along with a 1.5% gain for Ramsay Health Care Limited (ASX: RHC). Crown Resorts Ltd (ASX: CWN) also gained 0.9%.

Among the market’s best today were Aconex Ltd (ASX: ACX), Greencross Ltd (ASX: GXL) and Whitehaven Coal Ltd (ASX: WHC). The trio lifted 13.1%, 4.6% and 5%, respectively.

Here are Tuesday’s top stories:

  1. IPO: 5 Key Risks Facing Inghams Group Limited Investors
  2. How one master investor made a 926% gain in a single day’s trade
  3. Sirtex Medical Limited shares surge on AGM sales guidance update
  4. CRASH: Should you buy shares of Healthscope Ltd?
  5. Here’s why Bega Cheese Ltd is getting hammered today
  6. 3 blue-chip shares I think dividend investors should avoid

Disover How 1 Man Made 100x His Money After 50

Few know, that as Warren Buffett blew out the candles on his 50th birthday cake, he had just 1% of his current fortune. Think about it: At an age when most give up hope, Buffett was just getting started on the remaining 99% of his fortune. Goes to show you that it's never too late for you to potentially get rich. Which is why we've gathered the strategies we learned from Buffett, distilled them down to 11 simple lessons, and put it in an exclusive report for you to claim. Just click here to learn more about this handy investing guide.

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.